224 related articles for article (PubMed ID: 29691631)
1. Lovastatin synergizes with itraconazole against planktonic cells and biofilms of Candida albicans through the regulation on ergosterol biosynthesis pathway.
Zhou Y; Yang H; Zhou X; Luo H; Tang F; Yang J; Alterovitz G; Cheng L; Ren B
Appl Microbiol Biotechnol; 2018 Jun; 102(12):5255-5264. PubMed ID: 29691631
[TBL] [Abstract][Full Text] [Related]
2. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents.
Sanglard D; Ischer F; Parkinson T; Falconer D; Bille J
Antimicrob Agents Chemother; 2003 Aug; 47(8):2404-12. PubMed ID: 12878497
[TBL] [Abstract][Full Text] [Related]
3. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
[TBL] [Abstract][Full Text] [Related]
4. Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans.
Song JL; Lyons CN; Holleman S; Oliver BG; White TC
Med Mycol; 2003 Oct; 41(5):417-25. PubMed ID: 14653518
[TBL] [Abstract][Full Text] [Related]
5. A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate.
Dunkel N; Liu TT; Barker KS; Homayouni R; Morschhäuser J; Rogers PD
Eukaryot Cell; 2008 Jul; 7(7):1180-90. PubMed ID: 18487346
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms.
Nailis H; Vandenbosch D; Deforce D; Nelis HJ; Coenye T
Res Microbiol; 2010 May; 161(4):284-92. PubMed ID: 20170727
[TBL] [Abstract][Full Text] [Related]
7. Ergosterol gene expression in wild-type and ergosterol-deficient mutants of Candida albicans.
Pierson CA; Eckstein J; Barbuch R; Bard M
Med Mycol; 2004 Aug; 42(4):385-9. PubMed ID: 15473366
[TBL] [Abstract][Full Text] [Related]
8. Artemisinin elevates ergosterol levels of Candida albicans to synergise with amphotericin B against oral candidiasis.
Zhu C; Liao B; Ye X; Zhou Y; Chen X; Liao M; Cheng L; Zhou X; Ren B
Int J Antimicrob Agents; 2021 Sep; 58(3):106394. PubMed ID: 34197906
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals.
Watamoto T; Samaranayake LP; Egusa H; Yatani H; Seneviratne CJ
J Med Microbiol; 2011 Sep; 60(Pt 9):1241-1247. PubMed ID: 21474609
[TBL] [Abstract][Full Text] [Related]
10. A small subpopulation of blastospores in candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes.
Khot PD; Suci PA; Miller RL; Nelson RD; Tyler BJ
Antimicrob Agents Chemother; 2006 Nov; 50(11):3708-16. PubMed ID: 16966398
[TBL] [Abstract][Full Text] [Related]
11. TOP2 gene disruption reduces drug susceptibility by increasing intracellular ergosterol biosynthesis in Candida albicans.
Zheng H; Jiang YY; Wang Y; Jia XM; Yan TH; Gao PH; Yan L; Jiang LH; Ji H; Cao YB
J Med Microbiol; 2010 Jul; 59(Pt 7):797-803. PubMed ID: 20223895
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Candida albicans virulence factors by novel levofloxacin derivatives.
Shafreen RM; Muthamil S; Pandian SK
Appl Microbiol Biotechnol; 2014 Aug; 98(15):6775-85. PubMed ID: 24723295
[TBL] [Abstract][Full Text] [Related]
13. Azole resistance by loss of function of the sterol Δ⁵,⁶-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence.
Vale-Silva LA; Coste AT; Ischer F; Parker JE; Kelly SL; Pinto E; Sanglard D
Antimicrob Agents Chemother; 2012 Apr; 56(4):1960-8. PubMed ID: 22252807
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of fluconazole resistance and pathogenicity attributes of Lebanese Candida albicans hospital isolates.
Fattouh N; Hdayed D; Geukgeuzian G; Tokajian S; Khalaf RA
Fungal Genet Biol; 2021 Aug; 153():103575. PubMed ID: 34033880
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis.
Vila TV; Chaturvedi AK; Rozental S; Lopez-Ribot JL
Antimicrob Agents Chemother; 2015 Dec; 59(12):7611-20. PubMed ID: 26416861
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
Martel CM; Parker JE; Bader O; Weig M; Gross U; Warrilow AG; Rolley N; Kelly DE; Kelly SL
Antimicrob Agents Chemother; 2010 Nov; 54(11):4527-33. PubMed ID: 20733039
[TBL] [Abstract][Full Text] [Related]
17. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
Watamoto T; Samaranayake LP; Jayatilake JA; Egusa H; Yatani H; Seneviratne CJ
Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
[TBL] [Abstract][Full Text] [Related]
18. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
Feng W; Yang J; Xi Z; Qiao Z; Lv Y; Wang Y; Ma Y; Wang Y; Cen W
Microb Drug Resist; 2017 Jul; 23(5):563-570. PubMed ID: 27976986
[TBL] [Abstract][Full Text] [Related]
19. The possible molecular mechanisms of farnesol on the antifungal resistance of C. albicans biofilms: the regulation of CYR1 and PDE2.
Chen S; Xia J; Li C; Zuo L; Wei X
BMC Microbiol; 2018 Dec; 18(1):203. PubMed ID: 30509171
[TBL] [Abstract][Full Text] [Related]
20. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
